133 related articles for article (PubMed ID: 31809908)
21. Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions.
Bøtker JP; Karmwar P; Strachan CJ; Cornett C; Tian F; Zujovic Z; Rantanen J; Rades T
Int J Pharm; 2011 Sep; 417(1-2):112-9. PubMed ID: 21182911
[TBL] [Abstract][Full Text] [Related]
22. Generation of wear during the production of drug nanosuspensions by wet media milling.
Juhnke M; Märtin D; John E
Eur J Pharm Biopharm; 2012 May; 81(1):214-22. PubMed ID: 22269938
[TBL] [Abstract][Full Text] [Related]
23. Impact of media material and process parameters on breakage kinetics-energy consumption during wet media milling of drugs.
Parker N; Rahman M; Bilgili E
Eur J Pharm Biopharm; 2020 Aug; 153():52-67. PubMed ID: 32522681
[TBL] [Abstract][Full Text] [Related]
24. Effect of milling on particle shape and surface energy heterogeneity of needle-shaped crystals.
Ho R; Naderi M; Heng JY; Williams DR; Thielmann F; Bouza P; Keith AR; Thiele G; Burnett DJ
Pharm Res; 2012 Oct; 29(10):2806-16. PubMed ID: 22872437
[TBL] [Abstract][Full Text] [Related]
25. Preparation of theophylline inhalable microcomposite particles by wet milling and spray drying: The influence of mannitol as a co-milling agent.
Malamatari M; Somavarapu S; Kachrimanis K; Bloxham M; Taylor KMG; Buckton G
Int J Pharm; 2016 Nov; 514(1):200-211. PubMed ID: 27863663
[TBL] [Abstract][Full Text] [Related]
26. Development of a novel approach towards predicting the milling behaviour of pharmaceutical powders.
Kwan CC; Chen YQ; Ding YL; Papadopoulos DG; Bentham AC; Ghadiri M
Eur J Pharm Sci; 2004 Dec; 23(4-5):327-36. PubMed ID: 15567285
[TBL] [Abstract][Full Text] [Related]
27. Do Mixtures of Beads with Different Sizes Improve Wet Stirred Media Milling of Drug Suspensions?
Guner G; Mehaj M; Seetharaman N; Elashri S; Yao HF; Clancy DJ; Bilgili E
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765182
[TBL] [Abstract][Full Text] [Related]
28. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization.
Mallipeddi R; Saripella KK; Neau SH
Int J Pharm; 2010 Jan; 385(1-2):53-65. PubMed ID: 19853027
[TBL] [Abstract][Full Text] [Related]
29. Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.
Yuminoki K; Seko F; Horii S; Takeuchi H; Teramoto K; Nakada Y; Hashimoto N
J Pharm Sci; 2014 Nov; 103(11):3772-3781. PubMed ID: 25209659
[TBL] [Abstract][Full Text] [Related]
30. Cone milling of compacted flakes: process parameter selection by adopting the minimal fines approach.
Samanta AK; Ng KY; Heng PW
Int J Pharm; 2012 Jan; 422(1-2):17-23. PubMed ID: 22001841
[TBL] [Abstract][Full Text] [Related]
31. Development of Novel Bead Milling Technology with Less Metal Contamination by pH Optimization of the Suspension Medium.
Tanaka H; Ochii Y; Moroto Y; Ibaraki T; Ogawara KI
Chem Pharm Bull (Tokyo); 2021; 69(1):81-85. PubMed ID: 33390524
[TBL] [Abstract][Full Text] [Related]
32. Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view.
Afolabi A; Akinlabi O; Bilgili E
Eur J Pharm Sci; 2014 Jan; 51():75-86. PubMed ID: 24036164
[TBL] [Abstract][Full Text] [Related]
33. Engineering of acetaminophen particle attributes using a wet milling crystallisation platform.
Ahmed B; Brown CJ; McGlone T; Bowering DL; Sefcik J; Florence AJ
Int J Pharm; 2019 Jan; 554():201-211. PubMed ID: 30391338
[TBL] [Abstract][Full Text] [Related]
34. Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry.
Gaisford S; Dennison M; Tawfik M; Jones MD
Int J Pharm; 2010 Jun; 393(1-2):74-8. PubMed ID: 20385222
[TBL] [Abstract][Full Text] [Related]
35. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
Monteiro A; Afolabi A; Bilgili E
Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
[TBL] [Abstract][Full Text] [Related]
36. One step preparation of spherical drug particles by contamination-free dry milling technique with corn starch beads.
Niwa T; Yoshida M; Hayashi N; Kondo K
Int J Pharm; 2017 Aug; 528(1-2):624-636. PubMed ID: 28634141
[TBL] [Abstract][Full Text] [Related]
37. Investigation of the milling capabilities of the F10 Fine Grind mill using Box-Behnken designs.
Tan BM; Tay JY; Wong PM; Chan LW; Heng PW
Eur J Pharm Biopharm; 2015 Jan; 89():208-15. PubMed ID: 25497486
[TBL] [Abstract][Full Text] [Related]
38. Rapid development of API nano-formulations from screening to production combining dual centrifugation and wet agitator bead milling.
Hagedorn M; Liebich L; Bögershausen A; Massing U; Hoffmann S; Mende S; Rischer M
Int J Pharm; 2019 Jun; 565():187-198. PubMed ID: 31063837
[TBL] [Abstract][Full Text] [Related]
39. Pharmaceutical acrylic beads obtained by suspension polymerization containing cellulose nanowhiskers as excipient for drug delivery.
Villanova JC; Ayres E; Carvalho SM; Patrício PS; Pereira FV; Oréfice RL
Eur J Pharm Sci; 2011 Mar; 42(4):406-15. PubMed ID: 21241802
[TBL] [Abstract][Full Text] [Related]
40. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions.
Kumar S; Burgess DJ
Int J Pharm; 2014 May; 466(1-2):223-32. PubMed ID: 24614581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
